| Ms Aliya Mohre Caler, CNM, NP | |
|
524 Pennsylvania Ave, San Francisco, CA 94107-2914 | |
| (206) 349-6718 | |
| Not Available |
| Full Name | Ms Aliya Mohre Caler |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 524 Pennsylvania Ave, San Francisco, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063920502 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 235836 (California) | Primary |
| Entity Name | Planned Parenthood Mar Monte Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174579957 PECOS PAC ID: 1456248954 Enrollment ID: O20040301000438 |
News Archive
The University of Texas MD Anderson Cancer Center applauds new actions announced today by the U.S. Food and Drug Administration to limit the sale of most flavored electronic cigarettes to age-restricted locations and require age-verification for online sales to lower the use of these products in children.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
ACR Image Metrix™, an imaging contract research organization (CRO), exceeded its goals by initiating projects for over 30 pharmaceutical, biotechnology and medical device companies through its second full year of operation.
Each year, public health officials monitor the spread of influenza to identify which flu strains need to go into that year's vaccines and where outbreaks will occur. But it can be difficult to predict how bad a particular flu season will be until people actually start getting sick.
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received approval for three antiretroviral (ARV) therapies used to treat HIV/AIDS under the World Health Organization's (WHO) Prequalification of Medicines Programme. The products include:
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Aliya Mohre Caler, CNM, NP 524 Pennsylvania Ave, San Francisco, CA 94107-2914 Ph: (206) 349-6718 | Ms Aliya Mohre Caler, CNM, NP 524 Pennsylvania Ave, San Francisco, CA 94107-2914 Ph: (206) 349-6718 |
News Archive
The University of Texas MD Anderson Cancer Center applauds new actions announced today by the U.S. Food and Drug Administration to limit the sale of most flavored electronic cigarettes to age-restricted locations and require age-verification for online sales to lower the use of these products in children.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.
ACR Image Metrix™, an imaging contract research organization (CRO), exceeded its goals by initiating projects for over 30 pharmaceutical, biotechnology and medical device companies through its second full year of operation.
Each year, public health officials monitor the spread of influenza to identify which flu strains need to go into that year's vaccines and where outbreaks will occur. But it can be difficult to predict how bad a particular flu season will be until people actually start getting sick.
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received approval for three antiretroviral (ARV) therapies used to treat HIV/AIDS under the World Health Organization's (WHO) Prequalification of Medicines Programme. The products include:
› Verified 2 days ago
Ms. Judith T. Bishop, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 400 Parnassus Ave, San Francisco, CA 94143 Phone: 415-353-2566 Fax: 415-353-2496 | |
Mr. Lukas H Warren, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1036 14th St, San Francisco, CA 94114 Phone: 910-876-2636 | |
Gabrielle Westergren, RN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1001 Potrero Ave Rm 6d, San Francisco, CA 94110 Phone: 415-206-3409 | |
Susan Irene Mcdonald, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1580 Valencia St Ste 508, San Francisco, CA 94110 Phone: 415-641-2177 Fax: 415-641-2190 | |
Camila Constanza Soto Espinoza, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1855 4th St Fl 3, San Francisco, CA 94143 Phone: 415-353-2566 | |
Ms. Grace Loehr, CNM; NP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1855 4th St, San Francisco, CA 94143 Phone: 415-514-4612 |